rejuvant life tabs

AI app reveals your biological age – and how to slow it down

Latest articles

Can leucine turbo-charge longevity supplements and drugs?

Our exclusive interview with NuSirt’s founder explores how combining the sirtuin-activating amino acid has the potential to enhance the effect of longevity supplements and...

FOXO announces $10million investment to launch FOXO Life

FOXO Technologies Inc announces closing of $10 million investment to launch FOXO Life; continues commercialising epigenetic biomarker technology. FOXO Technologies Inc has announced that it...

Longevity supplements report: PDLH profile

The company behind Rejuvant, which partnered with the Buck Institute for Research on Aging on its calcium alpha-ketoglutarate longevity supplement. Over the coming weeks, we...

New research institute focuses on science of aging

New Bakar Aging Research Institute aims to drive deeply collaborative research to enhance translational medicine, progressing novel therapies from lab to clinic to community. UC...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...
Supplement report

Editor's picks

Can leucine turbo-charge longevity supplements and drugs?

Our exclusive interview with NuSirt’s founder explores how combining the sirtuin-activating amino acid has the potential to enhance the effect of longevity supplements and...

FOXO announces $10million investment to launch FOXO Life

FOXO Technologies Inc announces closing of $10 million investment to launch FOXO Life; continues commercialising epigenetic biomarker technology. FOXO Technologies Inc has announced that it...

Longevity supplements report: PDLH profile

The company behind Rejuvant, which partnered with the Buck Institute for Research on Aging on its calcium alpha-ketoglutarate longevity supplement. Over the coming weeks, we...
Rejuvant

Only as old as you feel … or only as old as your Young.AI app tells you?

We use our phones for just about everything these days; defying the aging process could be as straightforward as booking an Uber soon.

Longevity.Technology: The Hong Kong–based tech company Deep Longevity, which was recently acquired by Regent Pacific, has hit the headlines with its iPhone app Young.ai which aims to crunch biometric data via an easy-to-use smartphone app to interpret your biological age and provide you with a personalised Longevity strategy. Staying young? Now there’s an app for that …

Understanding and manipulating biological age unlocks the doors to far more therapies than just reading a chronological age from a data record. Biological age is calculated from health, lifestyle choices, genetic factors and accumulated damage; different organs age at different rates.

The Young.AI app, which is scheduled to debut on Apple’s app store on 29 September (an Android version is in the pipeline), will use a variety of deep aging clocks to calculate the user’s biological age, including blood test data, medical history, biomarkers, selfies and metrics from wearable fitness trackers like FitBit and Apple’s iWatch.

Once all the data is inputted, the app makes personalised suggestions that could slow, halt or even reverse the aging process.

Deep generative reinforcement learning is used by Deep Longevity, according to Founder and Chief Longevity Officer Alex Zhavoronkov, to: “track all the minute changes that transpire during aging (and then later manifest into diseases) very, very early and at many, many levels, so that we can identify longevity bottlenecks and we can identify various areas where we can intervene.”

Deep Longevity’s typical personalised report (from an earlier release).

Elevant

Young.AI is, says Zhavoronkov: “It’s a new field of AI-guided longevity medicine … focused on bringing you a little bit back – maybe a lot back – but initially … closer to the age of your optimal performance, which for humans is usually anywhere from 20 to 40.

“After that, unfortunately, we have a declining path. The idea is to use AI on every level to identify interventions and modifications that bring you back, from voice to pictures to psychology to transcriptomic level, proteomic level, ECG – anything! All things are connected.”

Longevity Technology Deep Aging Clock
Prospective Applications of Deep Aging Clocks in the Pharmaceutical and Biotechnology Industries. Source: Trends in Pharmacological Sciences

“Here we are executing on the vision of Dr Alex Zhavoronkov, the original inventor of deep aging clocks to provide the most advanced research tools in the hands of everyone on the planet without any biases towards social status, race, or gender to help optimize for much longer and healthier lives. With the launch of the integrated app and web system, we are establishing the foundation for the longevity ecosystem designed to produce quantifiable results and help extend human life and performance”, said Jamie Gibson, the CEO of Regent Pacific.

Image by Dariusz Sankowski from Pixabay

1 COMMENT

Comments are closed.

Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.
Rejuvant

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...
Supplement report

Related articles

Connected care start-up targets aging-in-place

PCL Health monitors key vitals at home, providing caregivers with peace of mind and supporting aging-in-place. British start-up PCL Health (formerly Poonyah Care) is on...

Gut bacteria start-up exits stealth with unique data

Wild Biotech plans to use database of more than 1,200 gut microbes to pursue novel drugs for human diseases and enhance CRISPR editing. Wild Biotech,...

AI first: novel drug target and novel molecule discovered

One step closer to senescence moonshot: Insilico claims industry first by nominating preclinical candidate for IPF, with both novel drug target and novel molecule...

Integrated nutrition platform for biohacking longevity

Span combines your data and 3rd party apps with expert guidance to boost longevity through biohacking personalised nutrition. British start-up Span is on a mission...

Skin patch reads both cardiovascular and metabolic biomarkers

UC San Diego researchers create the first wearable device for simultaneous monitoring of haemodynamic and biochemical biomarkers. Biohackers take note! Engineers at the University of...
Supps report ad middle